Nagoya University, which through its NU Tech program, is working with universities and private companies in RTP and the U.S., will host its third annual roundtable event on Oct. 4.
The topic is diagnostics and molecular therapeutics.
Technology from Nagoya, which is based in Japan and operates an office in RTP, North Carolina State University, University of North Carolina at Chapel Hill, and Wake Forest Institute for Regenerative Medicine will be on display and discussed.
Dr. Charles Nicolette, chief scientific officer at Argos Therapeutics, will be the keynote speaker.
The program begins at 8 a.m. at the North Carolina Biotechnology Center.
“The goal of the roundtable is strengthening the network beyond the borders among university researchers, startups in RTP, and business representatives from major and local pharmaceutical/healthcare companies, under the same specific interest in the research fields,” the university says. “NU expects the networks via Roundtable would lead to future research collaboration/licensing opportunities between universities and industries, under which the technology seeds would be further developed to commercialization by both parties.”
Registration is free.
